11 unknown. 11 Phase 2, 6 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Unknown 11 |
| Phase 3 | 6 | Unknown 6 |
| Phase 1 | 2 | Unknown 2 |
Follow Vaginitis: new trials by email Literature Review of Vaginitis trials Research Report on Vaginitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection BGY-1601-VT, PLACEBO - Bacterial Vaginosis, Vulvovaginal Candidiasis | Phase 1 / Phase 2 | Unknown | NEXBIOME THERAPEUTICS | 165 | 2024-07-08 | 2024-06-12 |
| Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause Vaginal Gel, Vaginal lubricant - Menopause Related Conditions, Atrophic Vaginitis | Phase 2 / Phase 3 | Unknown | Sarawak General Hospital | 52 | 2024-01-01 | 2023-12-28 |
| Role of Oral Lactoferrin in Prevention of Recurnt Bacterial Vaginosis in Pregnancy lactoferrin - Bacterial Vaginosis | Vaginal | Microbiology | Phase 2 / Phase 3 | Unknown | Zagazig University | 66 | 2022-07-01 | 2023-01-03 |
| A Clinical Trial for Chlorhexidine as Treatment for Vulvovaginal Candidiasis Chlorhexidine Gluconate, Fluconazole - Candidiasis, Vulvovaginal | Phase 2 | Unknown | Karolinska Institutet | 60 | 2022-04-27 | 2022-05-20 |
| A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC) Prof-001, Fluconazole 150 mg, Placebo cream - Recurrent Vulvovaginal Candidiasis | Phase 2 / Phase 3 | Unknown | ProFem GmbH | 432 | 2019-10-01 | 2022-09-22 |
| Patients With Vulvovaginal Candidiasis EPP-AF Gel 1%, EPP-AF Gel 2%, Clotrimazole - Vulvovaginal Candidiasis | Phase 1 / Phase 2 | Unknown | University of Sao Paulo | 90 | 2018-01-30 | 2018-10-19 |
| The Effect of Clindamycin and a Live Biotherapeutic on the Reproductive Outcomes of IVF Patients With Abnormal Vaginal Microbiota Clindamycin, Placebo - Bacterial Vaginoses, Infertility, Female | Phase 2 | Unknown | Peter Humaidan | 333 | 2017-12-07 | 2023-07-06 |
| Clinical Study to Evaluate the Efficacy of HUDC_VT in Patients With Bacterial Vaginosis HUDC_VT(Glucose 200mg/Sodium chloride 200mg), HUDC_VT (Glucose 400mg/Sodium chloride 200mg), HUDC_VT (Glucose 400mg) - Bacterial Vaginosis, HUDC_VT | Phase 2 | Unknown | Haudongchun Co., Ltd. | 150 | 2016-03-22 | 2017-12-02 |
| Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis Adelmidrol vaginal gel, Placebo vaginal gel - Vaginitis | Phase 2 / Phase 3 | Unknown | Università degli Studi dell'Insubria | 60 | 2011-09-01 | 2013-06-21 |
| A Pilot Open-label Randomized Study of Lactofiltrum in Women With Bacterial Vaginosis Lactofiltrum + Metronidazole, Metronidazole - Bacterial Vaginosis | Phase 2 / Phase 3 | Unknown | Avva Rus, JSC | 90 | 2010-07-01 | 2010-07-21 |
| The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients Lactobacillus rhamnosus GR-1 + Lactobacillus reuteri RC-14, Placebo, Metronidazole - HIV Infections, Diarrhea | Phase 2 / Phase 3 | Unknown | National Institute for Medical Research, Tanzania | 65 | 2007-10-01 | 2009-01-30 |
Vaginosis, Bacterial (6) · Candidiasis, Vulvovaginal (4) · Acquired Immunodeficiency Syndrome (1) · Atrophic Vaginitis (1) · Communicable Diseases (1) · Diarrhea (1) · HIV Infections (1) · Infertility, Female (1) · Sexual Dysfunction, Physiological (1) · Vulvovaginitis (1)
Female Urogenital Diseases (11) · Female Urogenital Diseases and Pregnancy Complications (11) · Genital Diseases (11) · Genital Diseases, Female (11) · Urogenital Diseases (11) · Vaginal Diseases (11) · Bacterial Infections and Mycoses (9) · Infections (9) · Bacterial Infections (6) · Candidiasis (4) · Mycoses (4) · Vulvar Diseases (4) · Vulvitis (4) · Vulvovaginitis (3)
Fluconazole (2) · Metronidazole (2) · Clindamycin (1) · Clotrimazole (1) · Glucose (1) · Lactoferrin (1) · Sodium Chloride (1) · Vaginal Creams, Foams, and Jellies (1) · chlorhexidine gluconate (1)
Avva Rus, JSC (1) · Haudongchun Co., Ltd. (1) · Karolinska Institutet (1) · NEXBIOME THERAPEUTICS (1) · National Institute for Medical Research, Tanzania (1) · Peter Humaidan (1) · ProFem GmbH (1) · Sarawak General Hospital (1) · University of Sao Paulo (1) · Università degli Studi dell'Insubria (1) · Zagazig University (1)
Austria (1) · Brazil (1) · Denmark (1) · Egypt (1) · Italy (1) · Poland (1) · Russia (1) · Slovakia (1) · South Korea (1) · Sweden (1) · Tanzania (1)
Amal Mohamed Alanwar, MD (1) · Cathrin Alvendal, MD, PhD (1) · Herbert Kiss, Prof. (1) · John Changalucha, MSc (1) · Lyudmila Kobeleva, MD, PhD (1) · Marian Asaad Gerges, MD (1) · Rania Samy Ezzat, MD (1) · Safaa Abdelsalam Ibrahim, MD (1) · Sergey Dvoryanskiy, MD, DrSc (1) · WonSeog Choi (1)